We are live on ! Find out more
ALNY icon

Alnylam Pharmaceuticals
ALNY

496 hedge funds and large institutions have $26.7B invested in Alnylam Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 118 funds opening new positions, 170 increasing their positions, 151 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

203% more first-time investments, than exits

New positions opened: 118 | Existing positions closed: 39

83% more funds holding in top 10

Funds holding in top 10: 6 → 11 (+5)

62% more capital invested

Capital invested by funds: $16.5B → $26.7B (+$10.2B)

18% more funds holding

Funds holding: 421 → 496 (+75)

17.7% more ownership

Funds ownership: 93.9% → 111.6% (+18%)

13% more repeat investments, than reductions

Existing positions increased: 170 | Existing positions reduced: 151

11% more call options, than puts

Call options by funds: $298M | Put options by funds: $270M

Holders
496
Holders Change
+75
Holders Change %
+17.81%
% of All Funds
8.54%
Holding in Top 10
11
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+83.33%
% of All Funds
0.19%
New
118
Increased
170
Reduced
151
Closed
39
Calls
$298M
Puts
$270M
Net Calls
+$28.8M
Net Calls Change
-$110M

Top Buyers

1
N
Nuveen
North Carolina
+$3.11B
2
Capital World Investors
Capital World Investors
California
+$698M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$133M
4
Holocene Advisors
Holocene Advisors
New York
+$123M
5
Invesco
Invesco
Georgia
+$109M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$625M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$262M
3
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$142M
4
AllianceBernstein
AllianceBernstein
Tennessee
-$114M
5
AG
Artal Group
Luxembourg
-$87.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
51
Jane Street
New York
$54.6M +$27.3M +143,137 +110%
California Public Employees Retirement System
52
California Public Employees Retirement System
California
$54M +$6.33M +33,205 +14%
EAM
53
Eagle Asset Management
Florida
$52.7M +$423K +2,217 +0.8%
Deutsche Bank
54
Deutsche Bank
Germany
$50.8M +$1.23M +6,437 +3%
Bank of America
55
Bank of America
North Carolina
$47.6M -$818K -4,288 -2%
N
56
Natixis
France
$45.3M +$41.6M +218,295 +2,821%
Two Sigma Investments
57
Two Sigma Investments
New York
$43.4M +$41.3M +216,712 New
California State Teachers Retirement System (CalSTRS)
58
California State Teachers Retirement System (CalSTRS)
California
$39.7M -$309K -1,620 -0.8%
Axa
59
Axa
France
$37.6M -$2.03M -10,618 -5%
Citigroup
60
Citigroup
New York
$36.8M +$8.4M +44,038 +31%
Dimensional Fund Advisors
61
Dimensional Fund Advisors
Texas
$35.3M +$542K +2,841 +2%
Millennium Management
62
Millennium Management
New York
$34.6M +$32.1M +168,318 +3,781%
National Pension Service
63
National Pension Service
South Korea
$32.9M -$4.56M -23,911 -13%
EHI
64
Eagle Health Investments
Connecticut
$32.4M +$2.35M +12,336 +8%
Franklin Resources
65
Franklin Resources
California
$31.9M +$608K +3,185 +2%
D.E. Shaw & Co
66
D.E. Shaw & Co
New York
$30.3M +$2.9M +15,221 +11%
New York State Common Retirement Fund
67
New York State Common Retirement Fund
New York
$29.6M -$974K -5,106 -3%
TCM
68
Tekla Capital Management
Massachusetts
$28.7M +$2.82M +14,800 +12%
Barclays
69
Barclays
United Kingdom
$28.3M +$2.91M +15,233 +12%
State Board of Administration of Florida Retirement System
70
State Board of Administration of Florida Retirement System
Florida
$27.8M +$37.2K +195 +0.1%
RhumbLine Advisers
71
RhumbLine Advisers
Massachusetts
$27.4M +$1.56M +8,174 +6%
Handelsbanken Fonder
72
Handelsbanken Fonder
Sweden
$25.5M -$8.47M -44,407 -26%
HighTower Advisors
73
HighTower Advisors
Illinois
$25.4M -$846K -4,438 -3%
CIBC Private Wealth Group
74
CIBC Private Wealth Group
Georgia
$23.9M +$604K +3,166 +3%
Skandinaviska Enskilda Banken (SEB)
75
Skandinaviska Enskilda Banken (SEB)
Sweden
$23.3M +$4.94M +25,905 +29%
1 2
3
4 5

ALNY Hedge Fund Activity: Q3 2022 in Review

496 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Alnylam Pharmaceuticals (ALNY) for Q3 2022, worth a combined $26.7B — up 62% from $16.5B a quarter earlier.

Buyers outnumbered sellers: 118 funds opened new ALNY positions and 39 closed out — a net gain of 79 holders — while 170 added to existing stakes and 151 trimmed.

The largest buyer was Nuveen, adding an estimated $3.11B. The largest seller was T. Rowe Price Associates, cutting an estimated $625M.

  • 496 institutional investors held Alnylam Pharmaceuticals (ALNY) as of Q3 2022, up from 421 in Q2 2022.
  • Funds reported $26.7B of Alnylam Pharmaceuticals stock for Q3 2022, up 62% quarter-over-quarter.
  • 118 funds opened new Alnylam Pharmaceuticals positions in Q3 2022 and 39 closed out, a net change of +79 holders.
  • The largest Alnylam Pharmaceuticals buyer in Q3 2022 was Nuveen, an estimated $3.11B added.
  • The largest Alnylam Pharmaceuticals seller in Q3 2022 was T. Rowe Price Associates, an estimated $625M sold.

Based on aggregated 13F filings for Q3 2022.